Professor Ren Hongliang from National University of Singapore Visits ROBO Medical for Academic Exchange

The 8th Asia-Oceania Congress of Physical Medicine and Rehabilitation Medicine (AOCPRM) was successfully held in Tianfu International Convention Center, Chengdu, China from October 7 to 9.ROBO Medical

Recently, ROBO Medical has fully independent intellectual property rights in the field of digestive endoscopic surgery robots

On August 15th, Weng Jiayan, Director of Hangzhou High tech Venture Capital Co., Ltd. and Executive Vice General Manager of Hangzhou Hehe Venture Capital Co., Ltd., as well as Ma Jia, Director of the Commerce Bureau of Hangzhou High tech Industrial Development Zone (Binjiang), and a delegation visited ROBO for medical exchange and guidance. Accompanied by General Manager Yang Jialin of ROBO Medical and others, Mr. Weng and his delegation had a discussion and exchange, gaining a deep understanding of the development history, business status, technical achievements, market applications, and other aspects of ROBO Medical. They also visited the company's latest research and development of a digestive endoscope surgical robot project, and gained a direct understanding of the company's main business and ongoing research projects. Medical robots are an emerging industry in recent years,

On July 28th, under the guidance of the Shandong Provincial Department of Science and Technology and organized by the Science and Technology Bureau of Lixia District, Jinan City, the high-level talent and technological achievements promotion conference for Lixia District was grandly held at the Qilu Science and Technology Finance Building in Jinan. At the meeting, Qilu Hospital of Shandong University and ROBO Medical held a signing ceremony for the collaborative research and development of a minimally invasive surgical robot system for digestive endoscopy. Since 2017, ROBO Medical has collaborated with Qilu Hospital of Shandong University to develop a digestive tract surgical robot, and has undertaken the "Key Technology and System of Minimally Invasive Surgery Robot for Digestive Endoscopy" project, a key research and development plan of the Ministry of Science and Technology

The Director of External Cooperation and Marketing Department of the Health Innovation Business Unit of the globally renowned biopharmaceutical company Bollinger Ingelheim came to Hangzhou to discuss the cooperation and promotion of stroke rehabilitation projects with ROBO Medical. Boehringer Ingelheim is a pharmaceutical company dedicated to human biopharmaceutical chemistry. It is the world's largest private pharmaceutical company and an expert in the field of stroke treatment. As a leader in the field of stroke, Berger Ingelheim proposed a "holistic solution for stroke".

On April 30th, the High tech Research and Development Center of the Ministry of Science and Technology organized experts to conduct a mid-term inspection of the 2019 National Key R&D Plan project "Key Technologies and Systems of Minimally Invasive Surgery Robots for Digestive Endoscopy", which our company participated in, in Jinan City, Shandong Province. The total budget of the "Key Technologies and Systems for Minimally Invasive Surgery Robots in Digestive Endoscopy" project is 22.82 million yuan, including 10.82 million yuan from the central government's special budget. This project is led by Shandong University, following the principle of full chain design and integrated implementation, and has collaborated with 10 advantageous units, including Rob Medical, to conduct research. Rob Medical is responsible for the research and development, overall integration, and production of some key technologies in this project